CG Oncology (CGON) Times Interest Earned (2023 - 2026)
CG Oncology's (CGON) quarterly Times Interest Earned came in at -$0.17 in Q1 2026, up 64.13% YoY from -$0.11 in Q1 2025, and down 100.1% on a QoQ basis from $173.93 in Q4 2025.
CG Oncology (CGON) Times Interest Earned (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Times Interest Earned data on file, last reported at -$0.17 in Q1 2026.
- Quarterly Times Interest Earned rose 64.13% year-over-year to -$0.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.56 (up 63.53% YoY) and the FY2025 annual result came in at -$0.96, up 9.37% from the prior year.
- Times Interest Earned retreated to -$0.17 in Q1 2026, from $173.93 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $173.93 in Q4 2025 to a low of -$634.15 in Q4 2024.
- A 4-year average of -$84.15 and a median of -$0.36 in 2025 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 127.43% in 2025, down 397.37% in 2025.
- Tracing CGON's Times Interest Earned over 4 years: stood at -$238.02 in 2023, then plunged by 166.43% to -$634.15 in 2024, then soared by 127.43% to $173.93 in 2025, then tumbled by 100.1% to -$0.17 in 2026.
- The last three Times Interest Earned figures came in at -$0.17 (Q1 2026), $173.93 (Q4 2025), and -$0.27 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.22 |
| Mar 31, 2026 | -0.17 |
| Dec 31, 2025 | 173.93 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -634.15 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.10 |
| Sep 30, 2023 | -238.02 |
| Jun 30, 2023 | -273.91 |
| Mar 31, 2023 | -35.87 |